The conferences, meetings, and scientific gatherings where our team shares the latest data.
Fedora's Scientific Advisory Board convenes to review pipeline progress and set scientific priorities for the year ahead, bringing together experts in anti-infective discovery and development.
Fedora presented its current lead, FPI-2119, across eight posters and two talks, detailing its activity against resistant Gram-negative infections and its first-in-class, non-β-lactam mechanism.
